Clinical Trial

Qatar Cardiometabolic Cohort

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Our objective is to create a cardiometabolic cohort that could be representative of the local population, consisting of Qataris and long-term residents, in order to identify the prevalence, risk factors, and clinical characteristics of cardiometabolic disorders, as well as the incidence of atherosclerotic cardiovascular disease events.
Trial Details
NCT Number NCT07675928
Lead Sponsor Weill Cornell Medical College in Qatar
Collaborators: Hamad Medical Corporation
Conditions Cardiometabolic Diseases
Enrollment 3,000 participants
Start Date 2026-06-01
Primary Completion 2036-06-30 (estimated)
Study Completion 2036-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-06-30